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Introduction
After the capture of leukocytes on blood vessel walls, they 
polarize and migrate on the endothelial cells (ECs) lining the 
vessels, which is thought to enable them to find optimal sites 
for transendothelial migration (TEM; Schenkel et al., 2004; 
Phillipson et al., 2006). Leukocytes transmigrate either at EC 
junctions (paracellular TEM) or through individual EC (trans-
cellular TEM; Carman and Springer, 2004; Millán et al., 2006; 
Vestweber, 2007). These different steps of TEM require the co-
ordinated control of adhesion and the cytoskeleton.
Rho GTPases regulate cytoskeletal dynamics and migra-
tion in many diverse cell types (Jaffe and Hall, 2005; Heasman 
and Ridley, 2008). In T cells and other leukocytes, expression of 
dominant-negative Rho GTPases or treatment with chemical in-
hibitors or bacterial toxins has implicated several Rho GTPases 
in leukocyte migration (Tybulewicz and Henderson, 2009). For 
example, inhibitors of the closely related Rho isoforms RhoA, 
RhoB, and RhoC and/or their downstream targets, ROCKs, 
have been reported to reduce leukocyte adhesion by inhibiting 
activation of the integrin LFA-1 (Giagulli et al., 2004) and to re-
duce migration and chemotaxis by inhibiting contraction of the 
uropod at the rear (Alblas et al., 2001; Vicente-Manzanares 
et al., 2002; Smith et al., 2003; Worthylake and Burridge, 2003). 
In knockout mice, Cdc42, Rac1, and Rac2 contribute to the re-
cruitment of leukocytes to inflamed sites (Roberts et al., 1999; 
Yamauchi et al., 2004; Szczur et al., 2006; Filippi et al., 2007), 
although their exact role in the individual steps of TEM is not 
yet defined. Studies using leukocytes from knockout mice have 
identified roles for Cdc42 and the Rac guanine nucleotide ex-
change factor (GEF) Tiam1 (Szczur et al., 2006; Gérard et al., 
2009) in TEM. However, to date, the roles of the 20 different 
Rho GTPases in leukocyte TEM have not been systematically 
addressed. In this study, we use an siRNA screen to identify which 
Rho GTPases affect T cell TEM and describe a key role for 
RhoA in this process.
Transendothelial migration (TEM) is a tightly regu-lated process whereby leukocytes migrate from the vasculature into tissues. Rho guanosine triphospha-
tases (GTPases) are implicated in TEM, but the contribu-
tions of individual Rho family members are not known. 
In this study, we use an RNA interference screen to identify 
which Rho GTPases affect T cell TEM and demonstrate that 
RhoA is critical for this process. RhoA depletion leads to 
loss of migratory polarity; cells lack both leading edge 
and uropod structures and, instead, have stable narrow 
protrusions with delocalized protrusions and contractions. 
By imaging a RhoA activity biosensor in transmigrating 
T cells, we find that RhoA is locally and dynamically acti-
vated at the leading edge, where its activation precedes 
both extension and retraction events, and in the uropod, 
where it is associated with ROCK-mediated contraction. 
The Rho guanine nucleotide exchange factor (GEF) GEF-H1 
contributes to uropod contraction but does not affect 
the leading edge. Our data indicate that RhoA activity is 
dynamically regulated at the front and back of T cells to 
coordinate TEM.
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RhoA-depleted cells were not deficient in ICAM-1 clustering; 
indeed, there was an increase in cells associated with ICAM-1 
clusters (Fig. 1 d), implying that cups might preferentially form 
around T cells that are unable to transmigrate. It has been re-
ported that Tiam1-null T cells have reduced paracellular TEM 
but are able to switch to transcellular TEM (Gérard et al., 2009). 
In contrast, RhoA-depleted cells did not switch to transcellular 
TEM (Fig. 1 d), suggesting that RhoA is required for both routes.
RhoA is required for T cell polarization  
on ECs
We investigated how RhoA knockdown affected T cell migra-
tory polarity on EC. Polarized cells were identified by their elon-
gated shape and polarized localization of F-actin at the leading 
edge and the MTOC in the uropod (Fig. 2 a). By 30 min after 
addition to EC, most control siRNA-transfected T cells were 
polarized (Fig. 2 b). RhoA depletion increased the number of 
unpolarized cells with two or more narrow protrusions and lack-
ing a broad lamellipodium. The MTOC localized in the center 
of the rounded cell body, and the narrow protrusions contained 
both F-actin and microtubules (Fig. 2 a). These protrusions moved 
very slowly in comparison with lamellipodia in control cells 
(Fig. 2 c and Videos 2 and 4). Some RhoA-depleted cells retained 
a broad lamellipodium but had an elongated tail and no clear uro-
pod. These cells failed to detach the rear from EC (Fig. 2 c and 
Video 3). The fraction of rounded cells with multiple protru-
sions increased with efficiency of RhoA knockdown (Fig. 2 b, 
RhoA siRNA 1 and 2), suggesting that intermediate RhoA lev-
els are sufficient for cells to extend a lamellipodium but not 
to maintain the level of actomyosin contractility required for 
uropod formation, whereas lamellipodia cannot form at lower 
RhoA levels.
RhoA depletion also affected the localization of other 
T cell migratory polarity markers. Polarized control cells accumu-
lated the integrin LFA-1 (CD11a/2) in the lamellal region and 
ICAM-3 and phosphorylated ezrin-radixin-moesin proteins 
(ERM [p-ERM]) in the uropod (Fig. 2 a; Sánchez-Madrid and 
Serrador, 2009). In RhoA-depleted cells with multiple protru-
sions, ICAM-3 and LFA-1 were no longer polarized, and p-ERM 
was not detectable. In RhoA-depleted cells with elongated tails, 
ICAM-3 was more diffusely localized on the plasma membrane 
toward the cell rear than in control cells, and LFA-1 localized 
in the tails as well as lamellae. p-ERM detected by immuno-
fluorescence appeared much reduced, which is consistent with a 
role for RhoA in stimulating ERM phosphorylation (Matsui 
et al., 1999).
RhoA is localized to and active at the 
leading edge and uropod of crawling and 
transmigrating T cells
To understand how RhoA affects migratory polarity and TEM, we 
examined RhoA localization. RhoA was enriched both at the lead-
ing edge and uropod of T cells during crawling and TEM (Fig. 3 a). 
To image RhoA activity, a RhoA Raichu probe (Yoshizaki et al., 
2003) modified to express GFP/RFP (Makrogianneli et al., 2009) 
was expressed in CEM cells. The fluorescence resonance 
energy transfer (FRET) efficiency of the probe is determined by 
Results and discussion
RhoA is required for T cell TEM
We initially determined which of the 20 Rho GTPase family 
members were expressed in primary T lymphoblasts and the 
T cell line, CCRF-CEM (CEM). We detected expression of 14 
Rho GTPases but not RhoC, RhoV, RhoJ, RhoD, or RhoE/Rnd3. 
Rnd2 was only detected in CEM cells and not T lymphoblasts 
(Fig. S1 b). Using a siRNA screen, we examined which of these 
Rho GTPases affected TEM (Fig. S1, a and c). RhoA depletion 
had the strongest effect on TEM. The extent of TEM inhibition 
correlated with the level of RhoA knockdown, as observed with 
two siRNAs that knocked down RhoA with different efficien-
cies or with lentivirally delivered shRNA (Fig. 1, a and b; and 
Fig. S1, c and d). Those cells that did complete TEM did so later 
than control cells (Fig. 1 c).
RhoA is highly homologous to RhoB and RhoC (Boureux 
et al., 2007), but RhoC was not detected in T cells (Fig. S1 b). 
RhoB knockdown was less efficient, and thus, we cannot rule 
out a contribution to TEM (Fig. S1 c). The screen also indicated 
an important role for Rac2, whereas Rac3 knockdown increased 
TEM (Fig. S1 a). Rac3 has not previously been studied in hemo-
poietic cells, largely because its expression is highest in neurons 
(Bolis et al., 2003). However, it has previously been shown to 
have an opposing effect to Rac1 in neuronal cell adhesion and 
differentiation (Hajdo-Milasinović et al., 2007). Knockdown 
of RhoGDI1 was recently reported to lead to reduced levels of 
RhoA, Rac1, and Cdc42 (Boulter et al., 2010). RhoA depletion 
did not alter Rac1 or Cdc42 levels significantly in CEM cells, al-
though Rac1 activity was reduced (Fig. S1 e). It is unlikely that 
this contributes to the TEM inhibition after RhoA knockdown, 
as Rac1 knockdown only marginally reduced TEM (Fig. S1 a).
Depletion of RhoA prevents T cell crawling 
on endothelium
To determine at which stage RhoA affected TEM, we observed 
T cell interactions with EC by time-lapse microscopy. Control 
siRNA–treated cells rapidly polarized and migrated, with a la-
mellipodium at the front and uropod at the rear (the uropod is a 
domain behind the nucleus containing the microtubule-organizing 
center [MTOC] and signaling and adhesion molecules such as 
ICAM-3; Sánchez-Madrid and Serrador, 2009). Most trans-
migrating cells used a paracellular pathway (75 ± 4% SEM of 
transmigrating cells; 18 ± 3% SEM of total cells adhered to EC; 
Fig. 1 d). RhoA knockdown cells did not polarize or crawl effi-
ciently on EC, and their migratory velocity was much lower 
than control cells (Fig. 1, d–f; and Video 1). Instead of having a 
single lamellipodium and uropod, RhoA-depleted cells had 
narrow protrusions extending from a rounded cell body. Most 
RhoA-depleted cells had two protrusions, generally at opposite 
sides of the cell body, but some cells had three or more protru-
sions (Fig. 1 f and Video 1). These protrusions extended and re-
tracted at the tips but did not move the cell body significantly.
Endothelial ICAM-1 clusters around adherent leukocytes 
forming transmigratory cups (Barreiro et al., 2002; Carman et al., 
2003; Carman and Springer, 2004; van Buul et al., 2007) that 
are thought to be involved in transmigration (Wittchen, 2009). 
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Figure 1. RhoA is required for T cell crawling and TEM. (a) CEM T cell TEM on Transwells (n ≥ 5). (b) RhoA expression in CEM cells relative to GAPDH 
(n = 3). (c) Time of TEM completion determined by time-lapse microscopy (control siRNA, n = 32 cells; RhoA siRNA, n = 21 cells; four experiments). 
Boxes, median, 25th, and 75th percentiles; whiskers, 5th and 95th percentiles; dots, outliers. (d, left) Endothelial ICAM-1 localization around CEM cells 
on EC. Arrows, ICAM-1 clusters. ICAM-1 localizes around transmigratory channel (middle) or clusters around T cell processes of RhoA-depleted cells 
(bottom). (right) Quantification of ICAM-1 clustering around nontransmigrating cells and transmigratory path (n = 4; ≥100 cells/experiment). Insets: 
magnification of regions of ICAM-1 clustering indicated by blue arrows. (e, left) Tracks of 20 representative cells on EC from time-lapse videos. (right) 
Mean velocity of tracked cells (n = 4; ≥38 cells/experiment). (f) Images from time-lapse videos of CEM cells crawling on and transmigrating across EC. 
(right) Outlines of asterisk-marked control (yellow) and RhoA siRNA (blue and green) cells. Arrows, migration direction of control cells; dashed lines, 
transmigrated regions. *, P < 0.05; **, P < 0.01; ***, P < 0.001. Error bars indicate mean ± SEM. Bars, 20 µm.
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Figure 2. RhoA is required for T cell polarity on ECs. (a) CEM cells on EC were stained for the indicated proteins. Representative RhoA knockdown cells 
with an elongated tail (middle) or two or more protrusions (bottom). Arrows, polarized protein localization in control cells; arrowheads, F-actin–rich protru-
sions in RhoA knockdown. (b) CEM cells on EC were scored for the indicated polarity categories (n = 3; ≥100 cells/experiment). *, P < 0.05; **, P < 0.01; 
***, P < 0.001; compared with siControl (black asterisks) or siRhoA-1 (red asterisks) determined by Student-Newman-Keuls repeated measure analysis of 
variance. (c) Images from time-lapse videos. (top) Polarized control cell migrating on EC. Arrows, lamellipodium; *, uropods. (middle) Polarized RhoA 
knockdown cell. Arrowheads, elongated tails. (bottom) Rounded RhoA knockdown cell with two protrusions. Error bars indicate mean ± SEM. Bars, 10 µm.
the GTP/GDP loading and thus reports RhoA activity. Localiza-
tion of the probe was similar to endogenous RhoA (Fig. S2 d). 
Live cell multiphoton fluorescence lifetime imaging microscopy 
(FLIM) was performed to examine the spatiotemporal regula-
tion of RhoA activity during T cell crawling and TEM. RhoA 
activity was observed in three regions: at the leading edge at 
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Figure 3. RhoA localizes to and is active at the leading edge and uropod during crawling and TEM. (a) RhoA (green) localization in CEM T cells or 
T lymphoblasts (T-LB) on EC. Pink, cell tracker dye. Maximum projections of 11–31 confocal z-stack images at 0.5-µm intervals. RhoA is enriched at the 
uropod (arrows) and leading edge (arrowheads). (right) Circles, uropods; dashed lines, lamellipodium under EC. (b and c) FLIM images of RhoA Raichu 
probe (wild type) were acquired every 45 s as cells migrated on (b) or transmigrated across (c) EC. RhoA activity localizes to the leading edge (white 
arrowheads), including filopodia during TEM (red arrowheads), the uropod during rear contraction (solid arrows), and in dynamic puncta in the lamellal 
region (dashed arrows). Probe intensity images identify uropod (asterisks) above and transmigrated lamella below EC. (d) The plasma membrane region 
of FLIM images from six videos was analyzed to quantify RhoA activity levels (mean FRET efficiency value) in each of four 90° segments (see Materials 
and methods). The center of the leading edge is center of the front segment. The sum of values in the front or back segment was compared with the two 
side segments. (e) F-actin localization in transmigrating CEM cell imaged by STED microscopy. (middle) Magnified image of boxed area shows filopodia 
extending from the leading edge (arrows). (right) Circle, uropod; dashed line, leading edge under EC. (f) Localization of Cd11a/L integrin (green) and 
F-actin (red) during TEM 30 min after addition of CEM cells to EC. Bars, 10 µm.
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It has been hypothesized that RhoA could act at the lead-
ing edge to stimulate actin polymerization via mDia proteins 
and/or actomyosin contraction via ROCKs and phosphorylated 
myosin light chain (p-MLC) (Vicente-Manzanares and Sanchez-
Madrid, 2004). Given the narrow protrusions and reduced pro-
trusion rate after RhoA depletion, we examined whether changes 
in leading edge membrane dynamics were associated with RhoA 
activity (Fig. 4 h). We observed frequent transient localized ac-
tivation of RhoA at the leading edge of T cells crawling on EC 
(Fig. S3, a–c), which was followed by either membrane exten-
sion (52 ± 7% SEM of discrete RhoA activity events) or retrac-
tion (36 ± 4% SEM). The remainder (12 ± 3% SEM) were not 
associated with extension or retraction in the next frame, al-
though 40% of these were followed by membrane extension or 
retraction within 90 s. These results imply that RhoA contrib-
utes to both extension and retraction events at the leading edge 
during migration, presumably acting via different effector com-
plexes. Indeed, RhoA effectors involved in extension and retrac-
tion localize to the leading edge of migrating T cells, including 
mDia1 (Fig. 4 i; Vicente-Manzanares et al., 2003), low ROCK1 
levels (Smith et al., 2003), myosin IIA (Rey et al., 2002), and 
p-MLC in over half of polarized cells (Fig. 4 j and Fig. S3 d), 
albeit often at lower intensity than at the rear.
Roles of ROCKs and the RhoGEF GEF-H1 
in the uropod
Consistent with the RhoA activation we observe during contrac-
tion in the uropod, p-MLC staining was enriched in the uropod 
of both crawling and transmigrating T cells (Fig. 4 j and Fig. S3 d), 
and RhoA-depleted cells had reduced p-MLC protein levels 
(Fig. 5 a), indicating that RhoA-mediated uropod contraction is 
involved in TEM. In T cells, ROCK inhibitors affect migration 
on ICAM-1 and fibronectin (Vicente-Manzanares et al., 2002; 
Smith et al., 2003); therefore, we investigated the role of ROCKs 
during crawling on EC and TEM by knocking down ROCK1 
and ROCK2 with siRNAs (Fig. S3 e) or treating cells with the 
ROCK inhibitor Y27632. The main phenotype induced by 
ROCK knockdown or inhibition was long tails at the rear (Fig. 5, 
b and c). Many Y27632-treated cells had lateral protrusions 
along these tails (Fig. 5 d ), similar to those observed in RhoA 
knockdown cells (Fig. 2 a), indicating that ROCKs act both to 
mediate uropod contraction and suppress lateral protrusions 
(Worthylake et al., 2001; Vicente-Manzanares et al., 2002; 
Smith et al., 2003; Worthylake and Burridge, 2003). Interest-
ingly, a significant increase in nonpolarized cells with two or 
more protrusions was observed in Y27632-treated cells, al-
though this was not as high as with RhoA knockdown (Fig. 5 c). 
We then compared how protrusions formed in RhoA knock-
down and Y27632-treated cells. Most RhoA-depleted cells 
formed protrusions by extension events from a rounded cell 
body (Fig. 5 e and Video 10). In contrast, most protrusions in 
Y27632-treated cells arose either through a tail retraction defect 
(40% of cells with two protrusions) in which a cell with a long 
tail changed direction and formed a second tail at the opposite 
side or through a tail retraction defect and extension of a thin 
protrusion at the front (37.5%; Video 10). The extension of thin 
protrusions could reflect a requirement for RhoA/ROCK-mediated 
regions of protrusion, at the uropod, and, in some cells where 
we imaged the basal plasma membrane, in dynamic puncta in 
the lamella behind the leading edge (Fig. 3, b and c; and Videos 
5–8). Peaks of RhoA activity on the plasma membrane were 
higher at the leading edge compared with sides (P = 0.04 by bi-
nomial test) and at the back compared with the sides (P = 0.01) 
in actively moving cells (Fig. 3 d). Cell F showed most activity 
at the back, presumably reflecting strong uropod contraction.
In cells undergoing TEM, we also observed RhoA activa-
tion in filopodia (Fig. 3 c) extending from the leading edge be-
neath EC (Fig. 3 e). Similar localization of active RhoA was 
observed in T cells fixed during TEM (Fig. S2 a). The lamellal 
puncta of high RhoA activity resemble the localization of LFA-1 
(Fig. 2 a and Fig. 3 f; Smith et al., 2005; Stanley et al., 2008), 
and thus, could represent regions of T cell adhesion to ICAM-1 
on the apical plasma membrane of EC and on the basal mem-
brane after TEM (Millán et al., 2006). FRET efficiency was not 
dependent on the probe concentration (Fig. S2, e and f). As a 
control, we used a dominant-negative RhoA T19N Raichu probe 
(Yoshizaki et al., 2003), which had a much lower FRET effi-
ciency compared with wild-type RhoA (Fig. S2, b and c; and 
Video 9). Expression of the Raichu probe did not detectably 
affect membrane dynamics, as determined by analysis of kymo-
graphs produced from videos of cells crawling on EC, nor did it 
affect cell polarity or TEM (Fig. S2, g–i).
RhoA activity is associated with both 
membrane extension and retraction events 
at the leading edge
The RhoA activity at the leading edge of T cells on EC was surpris-
ing because in neutrophil-like cells migrating in 2D, RhoA was re-
ported to be active mainly in the uropod (Wong et al., 2006), 
although occasional puncta of activity were observed near the front. 
However, RhoA is active in lamellipodia of fibroblasts, HeLa and 
MDCK cells, and in growth cones of neuroblastoma cells, where it 
is associated with plasma membrane protrusion (Kurokawa and 
Matsuda, 2005; Nakamura et al., 2005; Pertz et al., 2006; Picard 
et al., 2009). Therefore, we investigated how RhoA affected mem-
brane dynamics. The leading edge and uropod of control T cells 
typically moved forward at the same constant rate with membrane 
ruffles at the front of the lamellipodium (Fig. 4, a and b). In most 
RhoA-depleted cells, the two or more long protrusions were stable 
except for some extension and retraction at the tips (Fig. 4 c). 
Kymographs were produced to examine membrane dynamics on 
these processes (Fig. 4, d and e). Slight lateral movement of the 
narrow protrusions meant that a continuous kymograph could not 
be performed over the same time course as control cells, and thus, 
protrusion dynamics were examined in four consecutive time 
frames. The tips of protrusions in RhoA-depleted cells extended 
much slower than lamellipodia of control cells, and only very rarely 
ruffled. However, we observed some membrane ruffling and lamel-
lipodia along the protrusion perpendicular to the direction of exten-
sion (Fig. 4, f and g; and Video 4). In addition, local constrictions 
were observed along many protrusions, which is suggestive of 
myosin-mediated contraction. Protrusion and contraction are thus 
delocalized in the absence of RhoA and occur along protrusions 
rather than at the ends.
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Figure 4. RhoA activity is associated with both extension and retraction of the membrane at the leading edge. (a–g) Images and kymographs (of regions 
marked with red/blue arrows) from time-lapse videos. (f and g) RhoA knockdown cell images show ruffling (starting at arrow; 5 s) perpendicular to long 
extension. (f) Arrowheads, phase dark spherical accumulations (SA). Boxed region in f is magnified in g. (h) Overlays of consecutive time-lapse images 
of RhoA Raichu probe lifetime (color scale) and probe localization on plasma membrane (white). Cell 1 shows RhoA activity before membrane retraction, 
and cell 2 shows before both retraction and extension. Solid arrow, extension; dashed arrows, retraction. Cell outlines show 0- (dark blue) and 45-s (light 
blue) frames. (i) mDIA1 and F-actin localization in CEM cells on EC imaged by STED microscopy. (j) p-MLC and F-actin localization in CEM cells after 
30 min on EC. Arrows, p-MLC at leading edge; dashed line, transmigrated region. LE, leading edge; U, uropod; CB, cell body; SA, phase dark spherical 
accumulations along protrusions. Bars, 10 µm.
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the length of T cells on EC, similar to ROCK inhibitor treatment, 
but did not induce thin protrusions or loss of the lamellipodium 
(Fig. 5 g and Fig. S3 h). GEF-H1 can activate RhoA-mediated 
myosin II–based contraction after its release from depolymeriz-
ing microtubules (Chang et al., 2008). We have recently found that 
ROCKs destabilize microtubules in T cells (Takesono et al., 2010), 
and thus, RhoA/ROCK signaling in the uropod could establish 
a positive feedback loop by promoting GEF-H1 release from 
microtubules, which in turn would increase RhoA activity.
Our data indicate that RhoA has at least three functions 
during T cell TEM: at the leading edge, it is required for both 
membrane protrusion and retraction, each of which contributes 
to the formation and extension of lamellipodia on and under 
retraction events to form a broad lamellipodium. However, 
siRNA-mediated knockdown of ROCK1 and ROCK2 did not 
inhibit TEM as much as RhoA knockdown (Fig. S3 f), and thus, 
in addition to RhoA/ROCK-mediated contraction in the uropod 
and lamellipodium, it is likely that RhoA protrusive activity in 
the lamellipodia is important for TEM.
The localization of the RhoGEF GEF-H1 was investigated 
because it was previously reported to mediate RhoA activation at 
the leading edge of HeLa cells (Nalbant et al., 2009). In contrast, 
GEF-H1 localization was restricted to the uropod of crawling and 
transmigrating T cells (Fig. 5 f and Fig. S3 g), suggesting that its 
function is to activate RhoA locally at the rear. Supporting this 
hypothesis, siRNA-mediated knockdown of GEF-H1 increased 
Figure 5. Roles of ROCKs and GEF-H1 in T cell 
polarity on EC. (a) p-MLC levels in CEM cells. 
GAPDH, protein loading. Representative of 
four experiments. (b and c) Polarity quantifica-
tion after 30 min on EC for siRNA-transfected 
(48 h) or Y27632-treated (10-min preincu-
bation and continued presence) CEM cells 
(b, n = 3; c, n = 5; 100 cells/experiment). 
(d) Localization of F-actin, -tubulin, and ICAM-3 
after 30 min on EC in Y27632-treated cells 
(10-min preincubation and continued pres-
ence). Arrows, long tails; arrowheads, lateral 
protrusions. (e) Process of CEM cell protrusion 
formation on EC determined from 1-h time-
lapse videos (n = 40 cells/condition; three 
experiments). (f) GEF-H1 localization in CEM 
cells after 30 min on EC. LE, leading edge; 
U, uropod. (g) CEM cell length after 30 min 
on EC (n = 3; 50 cells/condition/experiment). 
*, P < 0.05; **, P < 0.01. Error bars indicate 
mean ± SEM. Bars, 10 µm.
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allowed to settle on HUVECs after which Y27632 was added, or RhoA 
knockdown cells were added to HUVECs and allowed to settle. Time-lapse 
videos were acquired for a minimum of 1 h, capturing 1 frame/min. Protru-
sions were classified based on having (a) a defect in tail retraction in com-
bination with a narrow leading edge (long tail and narrow leading edge), 
(b) a defect in tail retraction followed by a reverse in migratory direction and 
formation of a second long tail (two long tails), or (c) an extension of protru-
sions from a rounded cell body (extension from opposite sides of cell body).
FLIM/FRET assays
The use of the Raichu RhoA probe and negative control RhoA-T19N probe 
has previously been described (Yoshizaki et al., 2003). Probes were modi-
fied to express GFP and mRFP as described for Rac1 and Cdc42 biosen-
sors (Makrogianneli et al., 2009). Multiphoton time-correlated single 
photon counting FLIM was performed to quantify RhoA biosensor FRET. An 
inverted microscope (TE2000E; Nikon) combined with an in-house scanner 
(Peter et al., 2005) and either a solid-state–pumped (Verdi; Coherent) or 
self mode–locked Ti:Sapphire laser (Mira or Chameleon; Coherent) for 
multiphoton excitation was used. All images were acquired at a suitable 
spatial and time resolution to provide enough photon arrival times for 
accurate fluorescence decay fitting, while avoiding detector pile up, and 
analyzed by performing a single-exponential pixel fit in time-resolved 
image analysis software (TRI2; Peter et al., 2005; Barber et al., 2009; 
Makrogianneli et al., 2009; Carlin et al., 2010).
For fixed samples, transfected cells were added to HUVECs for 
30 min, fixed with 4% paraformaldehyde, mounted using fluorescent mount-
ing media (Dako), and imaged at room temperature using a 40× 1.4 NA 
oil immersion objective onto a charge-coupled device camera (Orca; 
Hamamatsu Photonics). For live samples, transfected cells were allowed to 
settle on HUVECs grown in microincubator plates (Smart Slide; Labtech 
International) to maintain them at 37°C and 5% CO2. Time-resolved images 
were acquired over 30 s every 45 s, to provide enough photons for fitting 
without saturating the detector; time resolution was reduced to 64 bins to 
optimize this. FRET efficiency is defined as 1  (fluorescence lifetime of 
donor and acceptor [GFP + RFP]/fluorescence lifetime of donor alone [GFP]). 
GFP alone lifetimes were measured at 2.25 (fixed) and 2.35 ns (live). 
Images were analyzed using TRI2 (Peter et al., 2005; Barber et al., 2009; 
Makrogianneli et al., 2009; Carlin et al., 2010) and ImageJ.
Localization analysis of RhoA activity was performed by thresholding 
the intensity image and finding the cell centroid. To determine the movement 
magnitude, the position of the maxima along radial lines was calculated for 
each angle, and the mean was compared with the mean of the previous time 
frame. The front of the leading edge was calculated by extrapolating the 
movement vector from the center of the cell. The outermost three pixels of the 
FLIM-FRET data were selected, thresholded, and categorized as front, back, 
or sides with each segment being 90° and the center of the leading edge 
being the center of the front segment. 0 ± 45° represented the front of the cell, 
the two sides were 45–135° and 45 to 135°, and the back was 180 ± 
45°. If the movement magnitude was >2 pixels, it was considered possible 
to make a meaningful front/back assignment. The mean FLIM/FRET value in 
each segment was calculated and compared. These tests were performed for 
those cells in which the changes in cell shape from frame to frame were suffi-
ciently small such that movement could be consistently categorized. Data 
were analyzed using a binomial statistical test.
To represent RhoA activity localization graphically, the front of the 
leading edge was identified as described in the previous paragraph. In the 
frames in which the movement magnitude was <2 pixels, the position of the 
front of the leading edge from the previous frame was used. The FLIM 
image was split into angular segments with the RhoA activation of the outer 
3 pixels being averaged. The movement of each angular segment was 
measured relative to the previous frame (note that this will include both the 
effects of global movement and shape changes). The mean value of the 
RhoA activation in each segment was calculated after thresholding.
Immunofluorescence
CEM T cells or T lymphoblasts were added to HUVECs and fixed after 
30 min for 15 min with 4% paraformaldehyde or 10% trichloroacetic acid 
(RhoA localization). Cells were permeabilized with 0.1% Triton X-100, blocked 
with 1% BSA, and incubated with FITC-conjugated anti–-tubulin (1:200), 
anti-Cd11a (1:50), anti–ICAM-3 (1:50), anti-RhoA (1:50), anti–p-MLC 
(1:50), anti-mDIA1 (1:100), and/or anti–p-ERM (1:100) antibodies for 1 h 
followed by Alexa Fluor 488– or 546–conjugated anti–rabbit or anti–mouse 
IgG secondary antibodies (1:200) and/or Alexa Fluor 546– or 647–
conjugated phalloidin (1:200) for 1 h, and mounted using fluorescent mount-
ing medium (Dako). Images were acquired at room temperature using a 
confocal microscope (LSM 510 META; Carl Zeiss, Inc.) with three single 
EC, and in the uropod, it is required for actomyosin-based con-
traction via ROCKs. We predict that RhoA activation for these 
three functions is independently regulated by different GEFs in 
response to the unique microenvironments in each cellular re-
gion. Furthermore, our data indicate that RhoA is locally activated, 
perhaps by a further GEF (Francis et al., 2006), at adhesion-like 
structures in the lamella.
Materials and methods
Reagents
The following antibodies and reagents were used from the indicated 
sources: mouse anti-Rac1 (clone 23A8) and rabbit anti-Rac2 (Millipore), 
rabbit anti-Rac3 (provided by A. Cox, University of North Carolina at 
Chapel Hill, Chapel Hill, NC), rabbit anti-RhoA (26C4), anti-RhoB, goat 
anti-RhoC (Santa Cruz Biotechnology, Inc.), sheep anti-RhoF (provided by 
H. Mellor, University of Bristol, UK), mouse anti-RhoJ, rabbit anti-RhoQ, goat 
anti-RhoU, rabbit anti-RhoBTB1, anti–ICAM-3 antibody (Abcam), RhoH anti-
body (provided by D. Williams, Children’s Hospital, Boston, MA), rabbit 
anti-Cdc42 and anti-pS19-MLC (Cell Signaling Technology), mouse anti-
RhoE as previously described (Riento et al., 2003), mouse anti-RhoG (pro-
vided by J. Meller and M. Schwartz, University of Virginia, Charlottesville, 
VA; Meller et al., 2008), mouse anti-ROCK1 and ROCK2, mouse anti-
mDIA1 (BD), FITC-conjugated anti–-tubulin antibody (clone DM1A; 
Sigma-Aldrich), mouse anti–GEF-H1 (provided by M. Balda, University 
College London, UK), Alexa Fluor 546– and 488–conjugated phalloidin 
(Invitrogen), recombinant human SDF-1 (CXCL12), ICAM-1/Fc chimera, 
TNF (R&D Systems), and fibronectin (Sigma-Aldrich).
Cell culture
CCRF-CEM T cells (CEM), T lymphoblasts, and human umbilical vein ECs 
(HUVECs) were cultured or purified and used as previously described 
(Millán et al., 2006; Takesono et al., 2010). HUVECs were stimulated with 
10 ng/ml TNF for 16 h before experiments.
siRNA and plasmid transfection
Two different siRNAs or pools of four siRNAs (Thermo Fisher Scientific) 
were used as indicated. Proliferating CEM cells (0.5 × 106) were tran-
siently transfected with 1.2 µM siRNA or up to 20 µg plasmid DNA using 
a nucleofector (Lonza) according to the manufacturer’s instructions, and 
used for experiments after siRNA transfection after 48–72 h or after plas-
mid DNA transfection after 24 h.
Quantitative PCR
Extracted mRNA was converted to cDNA and quantified using Primer De-
sign SYBR green qPCR mastermix and primers (ABI PRISM 7000; Applied 
Biosystems). Primer sets were validated for amplification efficiency of 
90–110%. Relative mRNA expression was determined by comparison with 
the reference gene, GAPDH, using the Pfaffl method (Pfaffl, 2001).
TEM in Transwell assays
HUVECs were seeded onto fibronectin-coated 5-µm Transwell filters or 
glass coverslips and grown to confluence, stimulated with TNF, and incu-
bated for 15 min with 300 ng/ml SDF-1 and washed. For time-lapse and 
immunofluorescence assays, the medium was replaced with CEM cells in 
medium. For Transwell assays, the medium was replaced with 200 µl CEM 
cell medium containing 1.5 × 105 CEM cells, and 600 µl CEM cell medium 
containing 30 ng/ml SDF-1 was added to the lower chamber. After 2 h, 
transmigrated cells were counted using a Casy counter.
Time-lapse microscopy, cell tracking, and analysis
CEM cells were added to confluent TNF-stimulated HUVECs, and images 
were acquired at 37°C and 5% CO2 using a time-lapse microscope 
(Eclipse TE 2000-E; Nikon) with a charge-coupled device camera (ORCA; 
Hamamatsu Photonics). Images were acquired every minute for 1–2 h using 
a 20× 0.45 NA objective or for high magnification (90×) every second 
using a 60× 1.4 NA oil immersion objective with 1.5× magnification. 
Images were acquired using MetaMorph software (MDS Analytical Tech-
nologies), and cells were tracked using ImageJ software (National Institutes 
of Health) and analyzed using the Chemotaxis plug in. Kymographs were 
produced in MetaMorph from 90× magnification videos. The method of pro-
trusion formation was quantified from time-lapse videos. CEM cells were 
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photomultiplier tube detectors mounted on a inverted microscope (AxioOb-
server Z1; Carl Zeiss, Inc.) using a 40× 1.3 NA oil immersion objective (Carl 
Zeiss, Inc.). Images were acquired using Zen software (Carl Zeiss, Inc.) and 
processed using Zen and Photoshop (Adobe). For stimulated emission depletion 
(STED) microscopy, CEM T cells were fixed 30 min after addition to EC, perme-
abilized, blocked, and stained with Atto 647N-phalloidin (Sigma-Aldrich) to 
localize F-actin and anti-mDIA1 antibodies and coverslips mounted using 
mounting media (ProLong; Invitrogen). Cells were imaged at room temperature 
with a 100× 1.4 NA oil immersion objective (Leica) using an STED microscope 
(TCS SP5 II; Leica) in STED mode (F-actin) or confocal mode (mDIA1).
For quantification of polarization, polarized CEM cells (labeled with 
Cell Tracker dye) were defined as cells with a morphologically polarized 
shape, F-actin accumulation at the front, and the MTOC (identified by -tubulin 
staining) behind the nucleus. 100 cells/coverslip were counted in a mini-
mum of three independent experiments.
For quantification of CEM cell length, siRNA-transfected CEM cells 
were labeled with Cell Tracker dye 72 h after transfection and added to 
EC. After 30 min, cells were fixed and stained for -tubulin and GEF-H1. 
For Y27632 experiments, Cell Tracker dye–labeled cells were preincu-
bated with Y27632 for 10 min and added to EC in the continued presence 
of Y27632, fixed after 30 min, and stained for -tubulin and F-actin. Con-
focal z-stack images were acquired and used to measure the cell length of 
crawling CEM T cells and to measure GEF-H1 staining intensity to identify 
GEF-H1–depleted cells.
Statistical analysis
Statistical significance was determined using a two-way paired Student’s 
t test unless otherwise indicated.
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Fig. S1 shows expression and roles of Rho GTPases in T cell TEM. Fig. S2 
shows localization of RhoA activity in T cells migrating on and across ECs. 
Fig. S3 shows the roles of RhoA, ROCKs, and GEF-H1 in T cells. Video 1 
shows that RhoA knockdown inhibits T cell TEM. Video 2 shows protru-
sion dynamics in a control T cell. Video 3 shows tail extension in a RhoA-
depleted T cell. Video 4 shows protrusion dynamics in a RhoA-depleted 
T cell. Videos 5 and 6 show localization of RhoA activity in crawling T cells. 
Videos 7 and 8 show localization of RhoA activity in transmigrating 
T cells. Video 9 shows localization of the control dominant-negative RhoA 
probe in a crawling T cell. Video 10 shows effects of Y27632 on T cell 
protrusions. Online supplemental material is available at http://www.jcb 
.org/cgi/content/full/jcb.201002067/DC1.
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